The Ontario government has launched the next phase of its life sciences strategy, investing $146 million to enhance research, innovation, and biomanufacturing. This initiative aims to create 5,000 jobs and solidify Ontario's position as a global leader in health sciences, with a focus on advancing R&D, unlocking capital, and supporting local companies. Key investments include funding for research infrastructure, lab access programs, and a new Life Sciences Scale-Up Fund to boost production capacity.